Jeffrey E. Johnson, M.D.

Jeffrey E. Johnson, M.D., is a surgical oncologist dedicated to helping patients navigate complex cancer diagnoses with clarity and confidence. He specializes in the management of melanoma and breast cancer, bringing together advanced surgical techniques and collaborative care to achieve the best possible outcomes.

Areas of Expertise

Dr. Johnson focuses on comprehensive, multimodality cancer care, integrating surgery with systemic and targeted therapies. His clinical focus includes:

• Lymph node surgery: Expert in sentinel lymph node biopsy for accurate staging and treatment planning and lymph node dissection for more complex cases.
• Intralesional therapy for melanoma: Offers localized treatment options to improve control of advanced disease.
• Tumor infiltrating lymphocyte (TIL) therapy: Performs surgical removal of metastatic tumors to help produce individualized cell therapy products for advanced melanoma.
• Neoadjuvant therapy: Coordinates pre-surgical treatment for melanoma and breast cancer to optimize surgical outcomes.
• Robotic nipple-sparing mastectomy: Minimally invasive approach that improves cosmetic results, preserves skin and nipple viability, and maintains oncologic safety for appropriate patients.
• High-risk breast cancer management: Provides counseling and surgical care for women with elevated genetic or familial risk.

Research and Clinical Leadership

Beyond his clinical practice, Dr. Johnson is committed to advancing cancer care through research. His work explores novel therapies for advanced melanoma, surgical innovation, and strategies to improve patient-centered outcomes. This dedication reflects his belief that the needs of the patient should guide innovation to transform the future of cancer treatment.